Published in J Infect Dis on December 01, 1989
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev (1998) 8.74
Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol (1994) 8.37
Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol (1998) 6.91
Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol (1999) 6.66
Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Infect Immun (1991) 4.63
DNA fingerprinting of Escherichia coli O157:H7 strains by pulsed-field gel electrophoresis. J Clin Microbiol (1992) 4.24
Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme electrophoresis and mdh sequence studies. Infect Immun (1997) 3.97
Comparison and genomic sizing of Escherichia coli O157:H7 isolates by pulsed-field gel electrophoresis. Appl Environ Microbiol (1993) 3.81
Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks. Proc Natl Acad Sci U S A (2008) 3.69
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun (1993) 3.36
Molecular microbiological investigation of an outbreak of hemolytic-uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J Clin Microbiol (1996) 3.03
Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun (1990) 3.02
Bacteriophage control of bacterial virulence. Infect Immun (2002) 2.97
Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man. Epidemiol Infect (1993) 2.94
Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol (1998) 2.80
The role of the eaeA gene in diarrhea and neurological complications in a gnotobiotic piglet model of enterohemorrhagic Escherichia coli infection. Infect Immun (1995) 2.69
Role for a phage promoter in Shiga toxin 2 expression from a pathogenic Escherichia coli strain. J Bacteriol (2001) 2.59
Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerg Infect Dis (2000) 2.51
Clonal structure and pathogenicity of Shiga-like toxin-producing, sorbitol-fermenting Escherichia coli O157:H-. J Clin Microbiol (1993) 2.43
Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications. J Bacteriol (2003) 2.43
Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis (2004) 2.40
Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev (2009) 2.20
Shiga toxins--from cell biology to biomedical applications. Nat Rev Microbiol (2009) 2.19
Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J Clin Microbiol (2002) 2.17
Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence. Infect Immun (2009) 2.07
Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis. J Clin Microbiol (2001) 1.99
Molecular epidemiology of Escherichia coli O157:H7 strains by bacteriophage lambda restriction fragment length polymorphism analysis: application to a multistate foodborne outbreak and a day-care center cluster. J Clin Microbiol (1993) 1.97
Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons. Infect Immun (1995) 1.93
Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. J Clin Microbiol (2000) 1.90
Probing genomic diversity and evolution of Escherichia coli O157 by single nucleotide polymorphisms. Genome Res (2006) 1.87
Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J Clin Microbiol (2002) 1.85
Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun (2003) 1.81
Childhood hemolytic uremic syndrome, United Kingdom and Ireland. Emerg Infect Dis (2005) 1.79
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect (1993) 1.72
The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Infect Immun (1994) 1.70
Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes. Appl Environ Microbiol (1996) 1.69
Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. J Clin Microbiol (2009) 1.69
Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Appl Environ Microbiol (2000) 1.67
Shiga toxin subtypes display dramatic differences in potency. Infect Immun (2011) 1.63
Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol (1993) 1.58
Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev (2004) 1.55
Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect (1995) 1.54
Isogenic lysogens of diverse shiga toxin 2-encoding bacteriophages produce markedly different amounts of shiga toxin. Infect Immun (1999) 1.53
Use of pulsed-field gel electrophoresis for epidemiological study of Escherichia coli O157:H7 during a food-borne outbreak. Appl Environ Microbiol (1995) 1.52
Multiplex PCR for direct detection of Shiga toxigenic Escherichia coli strains producing the novel subtilase cytotoxin. J Clin Microbiol (2005) 1.50
Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun (2002) 1.49
Shiga toxin-producing Escherichia coli isolates from cases of human disease show enhanced adherence to intestinal epithelial (Henle 407) cells. Infect Immun (1997) 1.44
Clonal diversity of Chilean isolates of enterohemorrhagic Escherichia coli from patients with hemolytic-uremic syndrome, asymptomatic subjects, animal reservoirs, and food products. J Clin Microbiol (1999) 1.44
Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol (2011) 1.42
Prevalence and characterization of non-O157 shiga toxin-producing Escherichia coli isolates from commercial ground beef in the United States. Appl Environ Microbiol (2011) 1.38
Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun (2005) 1.38
Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. Proc Natl Acad Sci U S A (1999) 1.34
Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun (1996) 1.30
A brief overview of Escherichia coli O157:H7 and its plasmid O157. J Microbiol Biotechnol (2010) 1.29
Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J Clin Microbiol (1994) 1.28
Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis (2003) 1.23
Production and characterization of protective human antibodies against Shiga toxin 1. Infect Immun (2002) 1.23
Evaluation of ribotyping as epidemiologic tool for typing Escherichia coli serogroup O157 isolates. J Clin Microbiol (1996) 1.21
Diversity and host range of Shiga toxin-encoding phage. Infect Immun (2004) 1.20
Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody. Infect Immun (2008) 1.19
Identification and characterization of a newly isolated shiga toxin 2-converting phage from shiga toxin-producing Escherichia coli. Infect Immun (1998) 1.19
Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells. Infect Immun (1999) 1.18
Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines. Infect Immun (1994) 1.18
Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol (1996) 1.18
Identification of Escherichia coli O157:H7 genomic regions conserved in strains with a genotype associated with human infection. Appl Environ Microbiol (2006) 1.17
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis (2008) 1.16
The common ovine Shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type. J Clin Microbiol (2001) 1.16
Prevalence and characterization of non-O157 Shiga toxin-producing Escherichia coli on carcasses in commercial beef cattle processing plants. Appl Environ Microbiol (2002) 1.16
Molecular analysis of Shiga toxigenic Escherichia coli O111:H- proteins which react with sera from patients with hemolytic-uremic syndrome. Infect Immun (1998) 1.15
Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli. Infect Immun (2005) 1.13
Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun (2003) 1.12
All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection. J Vet Sci (2008) 1.11
Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center. J Clin Microbiol (2012) 1.09
Molecular epidemiology of Escherichia coli O157:H7 by restriction fragment length polymorphism using Shiga-like toxin genes. J Clin Microbiol (1995) 1.08
Genotypic analyses of Escherichia coli O157:H7 and O157 nonmotile isolates recovered from beef cattle and carcasses at processing plants in the Midwestern states of the United States. Appl Environ Microbiol (2001) 1.07
Increased adherence and expression of virulence genes in a lineage of Escherichia coli O157:H7 commonly associated with human infections. PLoS One (2010) 1.06
Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome. Infect Immun (2007) 1.05
Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease. Microb Pathog (2011) 1.02
Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx2-EDL933 and/or stx2vhb subtypes. J Clin Microbiol (2003) 1.01
A novel murine infection model for Shiga toxin-producing Escherichia coli. J Clin Invest (2012) 1.01
A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli. Toxins (Basel) (2012) 1.00
Relationship of genetic type of Shiga toxin to manifestation of bloody diarrhea due to enterohemorrhagic Escherichia coli serogroup O157 isolates in Osaka City, Japan. J Clin Microbiol (2000) 1.00
Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity. Appl Environ Microbiol (2009) 1.00
Shiga Toxin (Stx) Classification, Structure, and Function. Microbiol Spectr (2014) 0.99
Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection. J Infect Dis (2009) 0.98
Monoclonal antibody to Shiga toxin 2 which blocks receptor binding and neutralizes cytotoxicity. Infect Immun (1999) 0.97
Verotoxin and ricin have novel effects on preproendothelin-1 expression but fail to modify nitric oxide synthase (ecNOS) expression and NO production in vascular endothelium. J Clin Invest (1998) 0.97
A novel Escherichia coli O157:H7 clone causing a major hemolytic uremic syndrome outbreak in China. PLoS One (2012) 0.97
Serotype O157:H7 Escherichia coli from bovine and meat sources. J Clin Microbiol (1991) 0.96
Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide. Pediatr Nephrol (2011) 0.96
Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins. Appl Environ Microbiol (2007) 0.96
Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice. Infect Immun (1999) 0.95
Molecular basis of differential B-pentamer stability of Shiga toxins 1 and 2. PLoS One (2010) 0.95
Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis. Appl Environ Microbiol (2004) 0.94
Structure and function of plasmid pColD157 of enterohemorrhagic Escherichia coli O157 and its distribution among strains from patients with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol (1998) 0.94
Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease. J Health Popul Nutr (2012) 0.93
Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10. Infect Immun (2013) 0.93
Comparison of shiga-toxigenic Escherichia coli prevalences among dairy, feedlot, and cow-calf herds in Washington State. Appl Environ Microbiol (2004) 0.93
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med (2000) 7.78
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med (1988) 5.92
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIV. COMPARATIVE STUDIES ON THE NUTRITIVE VALUE OF ORALLY AND INTRAVENOUSLY ADMINISTERED HUMAN SERUM ALBUMIN IN MAN. J Clin Invest (1948) 5.08
A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA (1994) 4.85
Genotypic variation in pathogenic Escherichia coli O157:H7 isolated from patients in Washington, 1984-1987. J Infect Dis (1989) 3.50
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Hiccups: causes and cures. J Clin Gastroenterol (1985) 3.25
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
The prevalence of Escherichia coli O157.H7 in dairy and beef cattle in Washington State. Epidemiol Infect (1994) 3.13
Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis (1990) 3.04
Genetic and phenotypic analysis of Escherichia coli with enteropathogenic characteristics isolated from Seattle children. J Infect Dis (1997) 2.78
Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA (1989) 2.73
Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology (1984) 2.72
Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology (1992) 2.65
Shiga-like toxin-producing Escherichia coli in Seattle children: a prospective study. Gastroenterology (1993) 2.57
An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med (1999) 2.56
A longitudinal study of Escherichia coli O157 in fourteen cattle herds. Epidemiol Infect (1997) 2.52
Pattern formation by lateral inhibition with feedback: a mathematical model of delta-notch intercellular signalling. J Theor Biol (1996) 2.45
Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis. Neuron (1996) 2.38
Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder. N Engl J Med (1983) 2.36
Role of the Escherichia coli O157:H7 O side chain in adherence and analysis of an rfb locus. Infect Immun (1996) 2.36
Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study. JAMA (1988) 2.26
Duration of detection of fecal excretion of Escherichia coli O157:H7 in cattle. J Infect Dis (1997) 2.26
The antigenic relationship of alcohol-soluble substances of corpus luteum to those of testis and brain. Am J Pathol (1941) 2.15
A statewide outbreak of Escherichia coli O157:H7 infections in Washington State. Am J Epidemiol (1990) 2.13
A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity. Chest (1993) 2.09
A comparison of human and bovine Escherichia coli O157:H7 isolates by toxin genotype, plasmid profile, and bacteriophage lambda-restriction fragment length polymorphism profile. J Infect Dis (1993) 2.08
Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis (1999) 2.04
Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci U S A (1991) 2.00
Escherichia coli O157:H7 as the predominant pathogen associated with the hemolytic uremic syndrome: a prospective study in the Pacific Northwest. Pediatrics (1987) 1.98
Liver transplantation in hemophilia A. Blood (1987) 1.98
Molecular epidemiology of Escherichia coli O157:H7 strains by bacteriophage lambda restriction fragment length polymorphism analysis: application to a multistate foodborne outbreak and a day-care center cluster. J Clin Microbiol (1993) 1.97
Evaluation of DNA probes for detection of Shiga-like-toxin-producing Escherichia coli in food and calf fecal samples. Appl Environ Microbiol (1990) 1.94
Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics (1997) 1.90
Intestinal obstruction due to bezoars. Am J Gastroenterol (1984) 1.83
Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect Immun (2001) 1.82
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Gastric acid hypersecretion in refractory gastroesophageal reflux disease. Gastroenterology (1990) 1.77
Positional information in chick limb morphogenesis. Nature (1973) 1.76
Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers. J Infect Dis (1990) 1.73
Babesiosis in Washington State: a new species of Babesia? Ann Intern Med (1993) 1.71
Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN(E. coli), among Escherichia coli isolates from patients with urosepsis. Infect Immun (2000) 1.68
Blood use in liver transplantation. Transfusion (1987) 1.63
Genetic diversity among toxigenic and nontoxigenic Vibrio cholerae O1 isolated from the Western Hemisphere. Epidemiol Infect (1991) 1.61
Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet (1977) 1.58
Perspective: the problem of non-O157:H7 shiga toxin (Verocytotoxin)-producing Escherichia coli. J Infect Dis (1996) 1.56
Biocontrol of Escherichia coli O157 with O157-specific bacteriophages. Appl Environ Microbiol (1999) 1.55
Organ transplantation in HIV-positive patients with hemophilia. N Engl J Med (1990) 1.52
Etiology and outcome of diarrhea after marrow transplantation: a prospective study. Gastroenterology (1994) 1.51
Asymptomatic structural liver disease in hemophilia. N Engl J Med (1978) 1.50
A prospective study of Shiga-like toxin-associated diarrhea in a pediatric population. J Pediatr Gastroenterol Nutr (1994) 1.49
A new system for defining endoscopic complications emphasizing the measure of importance. Gastrointest Endosc (1997) 1.48
Hemorrhagic colitis with Escherichia coli O157:H7 preceding adult hemolytic uremic syndrome. Arch Intern Med (1985) 1.48
Transmission of hepatitis B virus from adopted Asian children to their American families. Am J Public Health (1988) 1.46
The immunohistological diagnosis of E. coli O157:H7 colitis: possible association with colonic ischemia. Am J Gastroenterol (1998) 1.43
Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count? Arch Intern Med (1991) 1.42
Hepatitis C testing. Comparison of Ortho's EIA and RIBA II tests in 1,182 patients undergoing primary liver transplantation. Am J Clin Pathol (1992) 1.42
THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT, IN HEMOPHILIA, OF THE PARENTERAL ADMINISTRATION OF A FRACTION OF THE PLASMA GLOBULINS RICH IN FIBRINOGEN. J Clin Invest (1945) 1.41
Campylobacter isolates in the United States, 1982-1986. MMWR CDC Surveill Summ (1988) 1.40
DEANTIGENATED BEEF BLOOD PLASMA AS A POSSIBLE SUBSTITUTE FOR HUMAN BLOOD PLASMA. Science (1943) 1.39
Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology (1987) 1.39
Investigation of multidrug-resistant Salmonella serotype typhimurium DT104 infections linked to raw-milk cheese in Washington State. JAMA (1999) 1.38
Hospital charges for people with AIDS in Washington State: utilization of a statewide hospital discharge data base. Am J Public Health (1988) 1.37
Occurrence of Shiga-like toxin-producing Escherichia coli in retail fresh seafood, beef, lamb, pork, and poultry from grocery stores in Seattle, Washington. Appl Environ Microbiol (1994) 1.36
Meckel's diverticulum: pitfalls in scintigraphic detection in the adult. Am J Gastroenterol (1984) 1.33
The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation. J Immunol (1982) 1.32
Liver transplantation in a hemophiliac. N Engl J Med (1985) 1.32
The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: lack of evidence for ascertainment bias. Am J Epidemiol (1989) 1.31
von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res (2001) 1.27
Genetic Considerations in Familial Hemorrhagic Disease. I. The Sex-Linked Recessive Disorders, Hemophilia and PTC Deficiency. Am J Hum Genet (1963) 1.27
Nosocomial legionellosis, Paris, France. Evidence for transmission by potable water. Am J Med (1985) 1.26
Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease. Blood (1978) 1.26
Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost (1980) 1.26
Purpura in congenital and acquired rubella. N Engl J Med (1965) 1.25
A PCR specific for Escherichia coli O157 based on the rfb locus encoding O157 lipopolysaccharide. J Clin Microbiol (1998) 1.24
Characteristics of antibiotic-resistant Escherichia coli O157:H7 in Washington State, 1984-1991. J Infect Dis (1994) 1.24
Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease. Alcohol Clin Exp Res (1982) 1.22
Mechanisms of inward-rectifier K+ channel inhibition by tertiapin-Q. Biochemistry (1999) 1.22
Hyperendemic shigellosis in the United States: a review of surveillance data for 1967-1988. J Infect Dis (1991) 1.22
Hyaluronan as a propellant for epithelial movement: the development of semicircular canals in the inner ear of Xenopus. Development (1991) 1.20
Epidemic cholera in West Africa: the role of food handling and high-risk foods. Am J Epidemiol (1990) 1.19
Acquired-immunodeficiency-like syndrome in two haemophiliacs. Lancet (1983) 1.16
Factor VII deficiency. Am J Hematol (1981) 1.15
Risk factors for fireworks-related injury in Washington State. JAMA (1984) 1.14
Risk factors for development of toxic shock syndrome. Association with a tampon brand. JAMA (1982) 1.13
Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood (1985) 1.13
Ascites-induced LeVeen shunt coagulopathy. Ann Surg (1983) 1.10
Listeria monocytogenes sepsis and small cell carcinoma of the rectum: an unusual presentation of the acquired immunodeficiency syndrome. Am J Clin Pathol (1985) 1.10
Lymphoma presenting as a traumatic hematoma in an HTLV-III antibody-positive hemophiliac. N Engl J Med (1985) 1.09
Hemolytic uremic syndrome epidemiology: a population-based study in King County, Washington, 1971 to 1980. Pediatrics (1987) 1.09
Campylobacter infections: the emerging national pattern. Am J Public Health (1987) 1.09
High-resolution chromoendoscopy for the diagnosis of diminutive colon polyps: implications for colon cancer screening. Gastroenterology (1996) 1.09
Comparison of methods for the isolation of genital mycoplasmas from men. J Infect Dis (1976) 1.09